Showing results (461-470 of 14,576) with videos related to
Sort By:
Pageof 1,458
Pediatric Clinics of North America|May 27, 2008
Diabetic ketoacidosis in the pediatric ICUJames P Orlowski, Cheryl L Cramer, Mariano R FiallosThe Journal of General Physiology|February 1, 1997
ATP dependence of Na+/H+ exchange. Nucleotide specificity and assessment of the role of phospholipidsN Demaurex, R R Romanek, J Orlowski, et al.Appetite|June 23, 2012
Human sensory preconditioning in a flavor preference paradigmGregory J Privitera, Colleen P Mulcahey, Cassandra M OrlowskiThe Journal of Biological Chemistry|May 25, 2002
Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosisRobert Z Orlowski, George W Small, Yue Y ShiDrug Safety|May 8, 2002
Is aspirin a cause of Reye's syndrome? A case againstJames P Orlowski, Usama A Hanhan, Mariano R FiallosCurrent Cancer Drug Targets|January 21, 2011
Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs)D J Kuhn, R Z Orlowski, C C BjorklundJournal of Molecular and Cellular Cardiology|August 10, 2010
Angiotensin II inhibits the electrogenic Na+/HCO3- cotransport of cat cardiac myocytesVerónica C De Giusti, Alejandro Orlowski, Ernesto A AielloTherapeutics and Clinical Risk Management|May 14, 2009
Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myelomaJatin J Shah, Robert Z Orlowski, Sheeba K ThomasJournal of Vision|September 19, 2009
Spatial contrast sensitivity and grating acuity of barn owlsWolf M Harmening, Petra Nikolay, Julius Orlowski, et al.Cleveland Clinic Journal of Medicine|January 1, 1993
Forgoing life-supporting or death-prolonging therapy: a policy statementJ P Orlowski, R L Collins, S N CancianPageof 1,458